Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 6/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.60 |
| ▸ | TSHR | P16473 | 2/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | NPC1 | O15118 | 12/20 | 0.57 |
| ▸ | RAB9A | P51151 | 12/20 | 0.57 |
| ▸ | POLB | P06746 | 2/20 | 0.57 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.57 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.57 |
| ▸ | RELA | Q04206 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.50 |
| ▸ | MAPT | P10636 | 5/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20508319 | 0.88 | NPC1 (0.57) | HPGDSMN1; SMN2ALDH1A1HSD17B10CYP1A2 | |
| SCHEMBL20508264 | 0.88 | NPC1 (0.61) | HPGDSMN1; SMN2ALDH1A1HSD17B10CYP1A2 | |
| SCHEMBL20508275 | 0.86 | RAB9A (0.65) | HPGDSMN1; SMN2ALDH1A1HSD17B10CYP1A2 | |
| SCHEMBL23468384 | 0.85 | S1PR1 (0.51) | HPGDSMN1; SMN2ALDH1A1HSD17B10CYP1A2 | |
| SCHEMBL20508325 | 0.85 | KDM4E (0.68) | HPGDSMN1; SMN2ALDH1A1HSD17B10CYP1A2 | |
| SCHEMBL20508334 | 0.82 | KDM4E (0.51) | HPGDSMN1; SMN2ALDH1A1HSD17B10CYP1A2 | |
| SCHEMBL20508285 | 0.82 | AURKA (0.49) | HPGDSMN1; SMN2ALDH1A1HSD17B10CYP1A2 | |
| SCHEMBL20508266 | 0.81 | RAB9A (0.56) | HPGDSMN1; SMN2ALDH1A1HSD17B10CYP1A2 | |
| SCHEMBL20508272 | 0.80 | NPC1 (0.54) | HPGDSMN1; SMN2ALDH1A1HSD17B10CYP1A2 | |
| SCHEMBL29804862 | 0.80 | RAB9A (0.71) | HPGDSMN1; SMN2ALDH1A1HSD17B10CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11026426-B2 | Oxadiazole and phenol derivatives as antibacterial and/or herbicidal agents | NORTHERN ILLINOIS RESEARCH FOUNDATION (US) | 2021-06-08 | — | — | US | disclosed |
| US-11026426-B2 | Oxadiazole and phenol derivatives as antibacterial and/or herbicidal agents | NORTHERN ILLINOIS RESEARCH FOUNDATION (US) | 2021-06-08 | — | — | US | disclosed |
| US-20180271098-A1 | OXADIAZOLE AND PHENOL DERIVATIVES AS ANTIBACTERIAL AND/OR HERBICIDAL AGENTS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2018-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180271098-A1 | OXADIAZOLE AND PHENOL DERIVATIVES AS ANTIBACTERIAL AND/OR HERBICIDAL AGENTS | CMPK1, IPMK, ITPA | HPGD 808/4885SMN1; SMN2 4256/4885ALDH1A1 3151/4885 |
| US-11026426-B2 | Oxadiazole and phenol derivatives as antibacterial and/or herbicidal agents | CBR3, AOC3, AHR | HPGD 778/4885SMN1; SMN2 3949/4885ALDH1A1 594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.